BiotechTube

Topical Testosterone Solution

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Hypogonadism

Conditions

Hypogonadism

Trial Timeline

Jul 1, 2013 → Jan 1, 2014

NCT ID
NCT01893281

About Topical Testosterone Solution

Topical Testosterone Solution is a approved stage product being developed by Eli Lilly for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT01893281. Target conditions include Hypogonadism.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01893281ApprovedCompleted

Competing Products

20 competing products in Hypogonadism

See all competitors
ProductCompanyStageHype Score
Testosterone Solution + Placebo SolutionEli LillyPhase 3
77
Testosterone MD-LotionEli LillyPhase 2
52
Testosterone MD-LotionEli LillyPhase 3
77
Testosterone MD-LotionEli LillyPhase 3
77
Testosterone Gel 1.62% + Testosterone Gel 1.62%AbbViePhase 1
33
ABT-SLV176AbbViePhase 3
77
AndroGel® + PlaceboAbbVieApproved
85
AndroGel 1.62%AbbVieApproved
85
Recombinant human luteinizing hormone (r-hLH) + Recombinant human follicle-stimulating hormone (r-hFSH) + Human chorionic gonadotropin (hCG)MerckPhase 3
77
Oral testosterone undecanoate (Andriol) + PlaceboMerckPhase 2
52
Reference: Follitropin alfa + ZoladexMerckPhase 1
33
Testosterone + Alendronate + Placebo Alendronate + Placebo TestosteroneMerckPhase 2
52
Testosterone Enanthate + FinasterideMerckPhase 2
52
Testim 1% (testosterone gel) + PlaceboMerckPhase 2
52
Investigational new drug company code: BGS649 + PlaceboNovartisPhase 2
52
Test formulation + Reference formulationPfizerPhase 1
32
Testosterone ProductBayerPre-clinical
20
Testosterone undecanoate (TU) - NebidoTMBayerPhase 3
74
Testosterone Undeconate (Nebido-R, BAY86-5037)BayerPre-clinical
20
Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
82

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85